Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H H Bailey

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Cancer Journal From Scientific American|December 22, 1999
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancerE M Hartenbach, L S Harris, H H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology NetworkB S Kahl, W L Longo, J C Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Hematological Oncology|August 1, 2008
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network studyJ E Chang, P M Voorhees, J M Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Cancer Journal From Scientific American|December 22, 1999
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancerE M Hartenbach, L S Harris, H H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathioneH H Bailey, R T Mulcahy, K D Tutsch, et al.
Journal of the National Cancer Institute|December 10, 1997
Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalanH H Bailey, G Ripple, K D Tutsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology NetworkB S Kahl, W L Longo, J C Eickhoff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Phase I clinical trial of perillyl alcohol administered dailyG H Ripple, M N Gould, J A Stewart, et al.
Hematological Oncology|August 1, 2008
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network studyJ E Chang, P M Voorhees, J M Kolesar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a dayG H Ripple, M N Gould, R Z Arzoomanian, et al.
Pageof 3